Digital Services pave the way towards ‘Beyond the Pill’.
“Beyond the pill” is a frequent term for many years, but only now profitable Digital Health business models in pharma are becoming real. Syte supports pharma companies in adding reimbursed Digital Health services to their portfolio. Success in Digital Health reimbursement requires detailed Digital Health impact models, new market access approaches with insurances and ecosystem value based care process steps than are different from the classical non digital pharma experiences. We support in every step, from choosing the right technology partner over presenting profound medical and economic impact calculations for payors up to finalizing reimbursement agreements.
Pharma company, Digital Technology Provider, Insurance, Reference Hospitals and Clinics.
Digital service for reimbursement:
Monitoring of medication adherence, identification of deterioration patterns, early warning process.
Evaluation of Digital Health process structure, definition of medical and economic impact model focused on potential cost savings, pilot draft for validation of the economic model, presentation comprising the logic of processes and calculations for insurances, organization of feedback of health insurances regarding potential next steps, definition of implementation steps for a validation pilot in collaboration with the insurance, moderation of discussion between all stakeholders, strategy for scaling of the Digital Health technology.